Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
1 June 2024
| m 03:50 | Pembrolizumab (Keytruda) diffhist +203 Jwarner talk contribs →Renal cell carcinoma | ||||
20 May 2024
| m 13:28 | Study Groups diffhist -1 Jwarner talk contribs →Main table | ||||
17 May 2024
| m 22:05 | Urothelial carcinoma diffhist +2,836 Jwarner talk contribs | ||||
| m 16:04 | Surgery diffhist -11 Jwarner talk contribs →No surgery | ||||
13 May 2024
| m 13:39 | Study Groups diffhist +4 Jwarner talk contribs →Main table | ||||
9 May 2024
| 02:42 | Bladder cancer diffhist -13 Warner-admin talk contribs | ||||
6 May 2024
| m 17:59 | Urothelial carcinoma diffhist +4 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1417" | ||||
|
|
m 17:59 | Bladder cancer 2 changes history +9 [Warner-admin; Jwarner] | |||
| m |
|
17:59 (cur | prev) +4 Warner-admin talk contribs Text replacement - "https://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf" to "https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1417" | |||
| m |
|
17:58 (cur | prev) +5 Jwarner talk contribs →NCCN | |||